Ravindre Panchia to Diketopiperazines
This is a "connection" page, showing publications Ravindre Panchia has written about Diketopiperazines.
Connection Strength
0,050
-
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. Lancet. 2022 05 07; 399(10337):1779-1789.
Score: 0,050
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.